FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002597527> ?p ?o ?g. }

• W2002597527 endingPage "S100" @default.
• W2002597527 startingPage "S97" @default.
• W2002597527 abstract "Motor fluctuations and dyskinesia are common in advanced Parkinson's disease and can be poorly managed by current oral medications. Risk factors include the amount of l-dopa administered, gender and patient age. Continuous duodenal l-dopa or subcutaneous apomorphine infusions are helpful strategies because they can control motor complications by providing continuous dopaminergic drug delivery. Apomorphine subcutaneous infusion provides a motor benefit similar to that of dopamine and is relatively easy to use in advanced PD. However, it commonly requires concomitant administration of oral l-dopa and its long-term use is limited by compliance. Continuous administration of l-dopa/carbidopa by infusion in the duodenum/jejunum is a more complex procedure requiring a gastrostomy for the placement of the infusion tube, but it allows replacement of all oral medications and the achievement of a satisfactory therapeutic response paralleled by a reduction of motor complication severity. It should be noted that although these procedures are effective, most evidence relates to small case series and, particularly in the case of apomorphine, despite its long-term availability, there is a complete lack of randomized blinded studies. In addition, unlike deep brain stimulation, it is unclear which patients are the best candidates for these procedures, making any indirect comparison very complex, given the clinical heterogeneity of reported patients. This has consequences in resource allocation and in estimating cost–benefit ratios for these complex therapies in advanced PD." @default.
• W2002597527 created "2016-06-24" @default.
• W2002597527 creator A5009097001 @default.
• W2002597527 creator A5052133972 @default.
• W2002597527 date "2009-12-01" @default.
• W2002597527 modified "2023-09-27" @default.
• W2002597527 title "Pros and cons of apomorphine and l-dopa continuous infusion in advanced Parkinson's disease" @default.
• W2002597527 cites W175006040 @default.
• W2002597527 cites W1969522203 @default.
• W2002597527 cites W1971002934 @default.
• W2002597527 cites W1971654722 @default.
• W2002597527 cites W1972684129 @default.
• W2002597527 cites W1978720362 @default.
• W2002597527 cites W1988680456 @default.
• W2002597527 cites W1989738074 @default.
• W2002597527 cites W2002253478 @default.
• W2002597527 cites W2011418698 @default.
• W2002597527 cites W2013105613 @default.
• W2002597527 cites W2024242574 @default.
• W2002597527 cites W2024962747 @default.
• W2002597527 cites W2030419352 @default.
• W2002597527 cites W2033814944 @default.
• W2002597527 cites W2034770217 @default.
• W2002597527 cites W2034825135 @default.
• W2002597527 cites W2045023976 @default.
• W2002597527 cites W2047701363 @default.
• W2002597527 cites W2061460058 @default.
• W2002597527 cites W2067124523 @default.
• W2002597527 cites W2071991657 @default.
• W2002597527 cites W2075001845 @default.
• W2002597527 cites W2078208735 @default.
• W2002597527 cites W2078270115 @default.
• W2002597527 cites W2095889210 @default.
• W2002597527 cites W2097466872 @default.
• W2002597527 cites W2108476536 @default.
• W2002597527 cites W2111584279 @default.
• W2002597527 cites W2119080350 @default.
• W2002597527 cites W2121928725 @default.
• W2002597527 cites W2139669271 @default.
• W2002597527 cites W2141311399 @default.
• W2002597527 cites W2145667001 @default.
• W2002597527 cites W2151727783 @default.
• W2002597527 cites W2152727843 @default.
• W2002597527 cites W2164601556 @default.
• W2002597527 cites W2166211493 @default.
• W2002597527 cites W2169802060 @default.
• W2002597527 cites W2171479134 @default.
• W2002597527 cites W3149960943 @default.
• W2002597527 doi "https://doi.org/10.1016/s1353-8020(09)70844-2" @default.
• W2002597527 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20123567" @default.
• W2002597527 hasPublicationYear "2009" @default.
• W2002597527 type Work @default.
• W2002597527 sameAs 2002597527 @default.
• W2002597527 citedByCount "62" @default.
• W2002597527 countsByYear W20025975272012 @default.
• W2002597527 countsByYear W20025975272013 @default.
• W2002597527 countsByYear W20025975272014 @default.
• W2002597527 countsByYear W20025975272015 @default.
• W2002597527 countsByYear W20025975272016 @default.
• W2002597527 countsByYear W20025975272017 @default.
• W2002597527 countsByYear W20025975272019 @default.
• W2002597527 countsByYear W20025975272020 @default.
• W2002597527 countsByYear W20025975272021 @default.
• W2002597527 countsByYear W20025975272022 @default.
• W2002597527 countsByYear W20025975272023 @default.
• W2002597527 crossrefType "journal-article" @default.
• W2002597527 hasAuthorship W2002597527A5009097001 @default.
• W2002597527 hasAuthorship W2002597527A5052133972 @default.
• W2002597527 hasConcept C126322002 @default.
• W2002597527 hasConcept C137183658 @default.
• W2002597527 hasConcept C141071460 @default.
• W2002597527 hasConcept C177713679 @default.
• W2002597527 hasConcept C197934379 @default.
• W2002597527 hasConcept C2776754145 @default.
• W2002597527 hasConcept C2777525119 @default.
• W2002597527 hasConcept C2778542668 @default.
• W2002597527 hasConcept C2779134260 @default.
• W2002597527 hasConcept C2779384505 @default.
• W2002597527 hasConcept C2779734285 @default.
• W2002597527 hasConcept C2780304432 @default.
• W2002597527 hasConcept C2780405171 @default.
• W2002597527 hasConcept C42219234 @default.
• W2002597527 hasConcept C513476851 @default.
• W2002597527 hasConcept C71924100 @default.
• W2002597527 hasConceptScore W2002597527C126322002 @default.
• W2002597527 hasConceptScore W2002597527C137183658 @default.
• W2002597527 hasConceptScore W2002597527C141071460 @default.
• W2002597527 hasConceptScore W2002597527C177713679 @default.
• W2002597527 hasConceptScore W2002597527C197934379 @default.
• W2002597527 hasConceptScore W2002597527C2776754145 @default.
• W2002597527 hasConceptScore W2002597527C2777525119 @default.
• W2002597527 hasConceptScore W2002597527C2778542668 @default.
• W2002597527 hasConceptScore W2002597527C2779134260 @default.
• W2002597527 hasConceptScore W2002597527C2779384505 @default.
• W2002597527 hasConceptScore W2002597527C2779734285 @default.
• W2002597527 hasConceptScore W2002597527C2780304432 @default.
• W2002597527 hasConceptScore W2002597527C2780405171 @default.
• W2002597527 hasConceptScore W2002597527C42219234 @default.

• next